Has Jose Cuesta Camunas received payments from drug or device companies?

Yes. Drug and device makers reported $4,464 in general payments to Jose Cuesta Camunas across 179 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jose Cuesta Camunas did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jose Cuesta Camunas come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jose Cuesta Camunas

Dermatology · Bayamon, PRNPI 1134683873

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.5% of the total across 179 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by AbbVie at 36.0% of the total.

$4,464in general payments, 2019–2025

Across 179 payments — averaging $24.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$2K
Sanofi$802
Eli Lilly Export S.A. Puerto Rico Branch$511
Johnson & Johnson$460
E.r. Squibb & Sons, L.L.C.$294
PBG Puerto Rico LLC$258
plus $530 from 8 others

What the payments were for

Food & beverage$4,17493%
Education$2907%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	77	$1,609
Sanofi	24	$802
Eli Lilly Export S.A. Puerto Rico Branch	22	$511
Johnson & Johnson(2 entities)	17	$460
E.r. Squibb & Sons, L.L.C.	12	$294
PBG Puerto Rico LLC	12	$258
Sanofi-aventis U.S. LLC	2	$175
Amgen	6	$120
Madrigal Pharmaceuticals	1	$77
UCB, Inc.	2	$64
Incyte Corporation	1	$29
Sun Pharmaceutical Industries Inc.	1	$28
Krystal Biotech Inc	1	$22
Pfizer	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

DUPIXENT$122

How this compares

$4,464 in reported general payments places this provider in the 70th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Calcipotriene	30	$4,167
Clobetasol Propionate	58	$2,430
Ketoconazole	88	$2,169
Betamethasone Valerate	45	$1,707
Metronidazole	19	$1,485
Betamethasone Dipropionate	20	$1,293
Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc	26	$1,226
Desonide	16	$993
Mometasone Furoate	31	$900
Triamcinolone Acetonide	48	$883
Clindamycin Phosphate	20	$564
Doxycycline Monohydrate	11	$232
Prednisone	24	$191
Hydrocortisone	19	$136

Paid to pharmacies, not to this prescriber.

Other dermatology in Bayamon

See the full list for Puerto Rico →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →